NSCI

NETSCIENTIFIC PLC ORD 5P

TitleTime
PDS Reports Results for Q1 2020 & Business UpdateWed 13/05/20 | 14:46
Confirmation of Board ChangesFri 01/05/20 | 11:33
Preliminary Results for the year ended 31 Dec 2019Mon 27/04/20 | 07:00
Second Price Monitoring ExtnFri 17/04/20 | 16:40
Price Monitoring ExtensionFri 17/04/20 | 16:36
Second Price Monitoring ExtnFri 17/04/20 | 14:06
Price Monitoring ExtensionFri 17/04/20 | 14:00
Second Price Monitoring ExtnThu 16/04/20 | 16:40
Price Monitoring ExtensionThu 16/04/20 | 16:35
Board ChangesTue 31/03/20 | 07:00
Holding(s) in CompanyMon 30/03/20 | 09:39
Holding(s) in CompanyFri 14/02/20 | 15:12
PDS equity issue and related party transactionWed 12/02/20 | 11:07
PDS Biotechnology proposed offeringTue 11/02/20 | 14:24
Board ChangeWed 15/01/20 | 07:00
Holding(s) in CompanyWed 18/12/19 | 11:24
Holding(s) in CompanyTue 17/12/19 | 15:04
Board ChangesFri 13/12/19 | 13:21
Glycotest receives 2nd $3m tranche of $10m financeThu 21/11/19 | 07:00
Holding(s) in CompanyThu 17/10/19 | 14:14
Appointment to the BoardMon 14/10/19 | 07:00
PDS collaborates with Merck in Phase 2 studiesThu 03/10/19 | 13:44
PDS prioritise PDS0101 in high risk HPV to Phase 2Tue 01/10/19 | 14:10
PDS - positive data for immunotherapy treatmentThu 19/09/19 | 13:24
Interim Results for six months ended 30 June 2019Thu 19/09/19 | 11:00
PDS second quarter 2019 financial resultsThu 01/08/19 | 13:44
PDS Biotechnology Corp liquidity funding programWed 31/07/19 | 08:41
Holding(s) in CompanyTue 09/07/19 | 14:58
Holding(s) in CompanyMon 08/07/19 | 16:04
Result of Annual General MeetingTue 18/06/19 | 14:27
Positive new data demonstrates NEATstiks potentialFri 31/05/19 | 07:00
Notice of AGM and Annual Report & AccountsFri 24/05/19 | 09:50
Full Year Results for the year ended 31 Dec 2018Wed 22/05/19 | 07:00
PDS Biotechnology journal publicationThu 16/05/19 | 15:07
Resignation of CEOThu 25/04/19 | 07:00
Sale of Wanda and VortexFri 22/03/19 | 16:42
PDS merger with Edge Therapeutics updateTue 19/03/19 | 07:00
PDS completes merger with Edge TherapeuticsMon 18/03/19 | 14:09
Orderly wind up of Wanda and VortexMon 18/03/19 | 14:07
Share Price MovementThu 14/03/19 | 07:00
Results of General MeetingMon 04/03/19 | 11:45
Update on upcoming General MeetingFri 01/03/19 | 11:15
Second Price Monitoring ExtnWed 27/02/19 | 16:40
Price Monitoring ExtensionWed 27/02/19 | 16:35
Second Price Monitoring ExtnWed 27/02/19 | 14:05
Price Monitoring ExtensionWed 27/02/19 | 14:00
Holding(s) in CompanyMon 25/02/19 | 12:54
Holding(s) in CompanyThu 21/02/19 | 16:35
Holding(s) in CompanyWed 20/02/19 | 10:51
Second Price Monitoring ExtnTue 19/02/19 | 14:06
Price Monitoring ExtensionTue 19/02/19 | 14:00
Holding(s) in CompanyMon 18/02/19 | 16:54
Second Price Monitoring ExtnMon 18/02/19 | 11:06
Price Monitoring ExtensionMon 18/02/19 | 11:00
Conclusion of Strategic ReviewFri 15/02/19 | 12:00
Glycotest Receives First $3m Tranche from FosunThu 14/02/19 | 12:07
Termination of Formal Sales ProcessTue 15/01/19 | 11:08
Form 8.5 - NetScientific plcTue 15/01/19 | 09:37
Form 8.5 - NetScientific PLCMon 14/01/19 | 10:25
Form 8.5 - NetScientific PLCTue 08/01/19 | 11:58
Form 8.5 - NetScientific PLCMon 07/01/19 | 10:14
Form 8.5 - NetScientific PLCFri 04/01/19 | 09:13
Form 8.5 - NetScientific PLCMon 31/12/18 | 09:36
Form 8.5 - NetScientific PLCMon 24/12/18 | 10:23
Form 8.5 - NetScientific PLCFri 21/12/18 | 11:04
Second Price Monitoring ExtnThu 20/12/18 | 16:41
Price Monitoring ExtensionThu 20/12/18 | 16:36
Form 8.5 - NetScientific PLCThu 20/12/18 | 10:28
Update on Strategic ReviewThu 20/12/18 | 07:00
Form 8.3 - NetScientific PlcWed 19/12/18 | 11:03
Form 8.3 - NetScientific plcWed 19/12/18 | 11:00
Form 8.5 - NetScientific PLCWed 19/12/18 | 09:34
Form 8.5 - NetScientific PLCTue 18/12/18 | 09:32
Form 8.5 - NetScientific PLCThu 13/12/18 | 09:06
Form 8.5 - NetScientific PLCFri 07/12/18 | 10:23
Form 8.5 - NetScientific PLCWed 05/12/18 | 09:14
Form 8.5 - NetScientific PLCTue 04/12/18 | 09:50
Form 8.5 - NetScientific PLCMon 03/12/18 | 10:31
Form 8 (OPD) - NetScientific (Offeree)Fri 30/11/18 | 15:46
Form 8.5 - NetScientific PLCFri 30/11/18 | 11:35
Form 8.3 - NetScientific PlcThu 29/11/18 | 13:29
Form 8.3 - NetScientific PlcThu 29/11/18 | 12:49
Form 8.5 - NetScientific PLCThu 29/11/18 | 10:26
Form 8.3 - NetScientific PlcWed 28/11/18 | 13:46
Form 8.5 - NetScientific PLCWed 28/11/18 | 09:51
Invesco Ltd.: Form 8.3 - Netscientific PlcTue 27/11/18 | 12:44
Form 8.3 - NetScientfic PlcTue 27/11/18 | 12:34
Form 8.5 - NetScientific PLCTue 27/11/18 | 10:33
Form 8.3 - NetScientific PLCTue 27/11/18 | 09:36
Amendment to Executive Director Service TermsMon 26/11/18 | 15:01
Announcement of Strategic ReviewMon 26/11/18 | 15:00
PDS Announces Merger with Edge TherapeuticsMon 26/11/18 | 12:30
Glycotest Completes $10m Series A Round with FosunMon 22/10/18 | 13:01
Interim ResultsFri 28/09/18 | 07:00
Wanda Launches CareLink, New Digital Health AppWed 15/08/18 | 07:00
Change of AdviserThu 02/08/18 | 07:00
Grant of Options to DirectorsTue 26/06/18 | 16:24
Result of AGMThu 21/06/18 | 13:33
Bob Englert Appointed CEO of Vortex BiosciencesWed 06/06/18 | 07:00
Notice of AGM and Annual Report & AccountsTue 22/05/18 | 16:21
Directors Dealing NotificationWed 18/04/18 | 17:08
Result of General MeetingMon 16/04/18 | 14:04
Result of PlacingWed 11/04/18 | 11:39
Posting of CircularTue 03/04/18 | 16:09
Proposed Placing and SubscriptionThu 29/03/18 | 07:00
Full Year ResultsThu 29/03/18 | 07:00
ProAxsis Reports First NEATstik SaleThu 15/02/18 | 07:00
NetScientific Portfolio UpdateTue 16/01/18 | 07:00
ProAxsis Achieves CE Mark for Plasmin ImmunoassayMon 08/01/18 | 07:00
GlycotestT Completes Diagnostic EvaluationThu 04/01/18 | 07:00
ProAxsis: Sales UpdateTue 21/11/17 | 07:00
Vortex Announces First Commercial VTX-1 SaleTue 07/11/17 | 07:00
HRS Expands Use of Wanda to All PatientsFri 03/11/17 | 11:00
ProAxsis Partnership - US National Jewish HealthFri 27/10/17 | 07:00
Directorate ChangeWed 25/10/17 | 07:00
2017 Interim ResultsThu 28/09/17 | 07:00
ProAxsis Signs Partnership: Biotechnology CompanyMon 11/09/17 | 07:00
Notice of Interim ResultsThu 07/09/17 | 07:00
ProAxsis is awarded a European CE MarkMon 04/09/17 | 07:00
PDS Announces Clinical Collaboration with MerckMon 10/07/17 | 12:00
Glycotest UpdateMon 26/06/17 | 07:00
Result of AGMWed 21/06/17 | 12:00
Holdings in CompanyFri 16/06/17 | 10:05